[Chinese expert consensus on meibomian gland dysfunction: diagnosis and management (2023)].

Meibomian gland dysfunction (MGD) is a common ocular surface disease. In recent years, the meibomian gland-related examination and treatment technologies have evolved rapidly. In order to further optimize the diagnostic process of MGD in China and improve the treatment efficiency of MGD, the Chinese Branch of the Asian Dry Eye Society has organized relevant experts to discuss the clinical characteristics of MGD in China and the progress of research at home and abroad. Based on the expert consensus formed in 2017, the updated consensus opinions have been developed for clinical physicians to refer to in the diagnosis and management of MGD.睑板腺功能障碍（MGD）是临床常见的眼表疾病。近年来睑板腺相关检查和治疗技术发展迅速，为了进一步优化我国MGD的诊断流程，提高MGD的治疗效果，亚洲干眼协会中国分会等相关学术组织的专家，根据我国MGD的临床特点，结合近年国内外研究进展和临床实践经验，基于《我国睑板腺功能障碍诊断与治疗专家共识（2017年）》，针对MGD的检查方法、诊断标准和治疗方法进行讨论，形成新的共识性意见，以供临床医师在工作中参考。.